Your browser doesn't support javascript.
loading
New Mechanistic Insights, Novel Treatment Paradigms, and Clinical Progress in Cerebrovascular Diseases.
Boltze, Johannes; Aronowski, Jaroslaw A; Badaut, Jerome; Buckwalter, Marion S; Caleo, Mateo; Chopp, Michael; Dave, Kunjan R; Didwischus, Nadine; Dijkhuizen, Rick M; Doeppner, Thorsten R; Dreier, Jens P; Fouad, Karim; Gelderblom, Mathias; Gertz, Karen; Golubczyk, Dominika; Gregson, Barbara A; Hamel, Edith; Hanley, Daniel F; Härtig, Wolfgang; Hummel, Friedhelm C; Ikhsan, Maulana; Janowski, Miroslaw; Jolkkonen, Jukka; Karuppagounder, Saravanan S; Keep, Richard F; Koerte, Inga K; Kokaia, Zaal; Li, Peiying; Liu, Fudong; Lizasoain, Ignacio; Ludewig, Peter; Metz, Gerlinde A S; Montagne, Axel; Obenaus, Andre; Palumbo, Alex; Pearl, Monica; Perez-Pinzon, Miguel; Planas, Anna M; Plesnila, Nikolaus; Raval, Ami P; Rueger, Maria A; Sansing, Lauren H; Sohrabji, Farida; Stagg, Charlotte J; Stetler, R Anne; Stowe, Ann M; Sun, Dandan; Taguchi, Akihiko; Tanter, Mickael; Vay, Sabine U.
Afiliação
  • Boltze J; School of Life Sciences, University of Warwick, Warwick, United Kingdom.
  • Aronowski JA; Institute for Stroke and Cerebrovascular Diseases, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, United States.
  • Badaut J; NRS UMR 5287, INCIA, Brain Molecular Imaging Team, University of Bordeaux, Bordeaux cedex, France.
  • Buckwalter MS; Departments of Neurology and Neurological Sciences, and Neurosurgery, Wu Tsai Neurosciences Institute, Stanford School of Medicine, Stanford, CA, United States.
  • Caleo M; Neuroscience Institute, National Research Council, Pisa, Italy.
  • Chopp M; Department of Biomedical Sciences, University of Padua, Padua, Italy.
  • Dave KR; Department of Neurology, Henry Ford Hospital, Detroit, MI, United States.
  • Didwischus N; Department of Physics, Oakland University, Rochester, MI, United States.
  • Dijkhuizen RM; Peritz Scheinberg Cerebral Vascular Disease Research Laboratory, Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, United States.
  • Doeppner TR; School of Life Sciences, University of Warwick, Warwick, United Kingdom.
  • Dreier JP; Biomedical MR Imaging and Spectroscopy Group, Center for Image Sciences, University Medical Center Utrecht and Utrecht University, Utrecht, Netherlands.
  • Fouad K; Department of Neurology, University Medical Center Göttingen, Göttingen, Germany.
  • Gelderblom M; Department of Neurology, Center for Stroke Research Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Gertz K; Department of Experimental Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Golubczyk D; Bernstein Center for Computational Neuroscience Berlin, Berlin, Germany.
  • Gregson BA; Einstein Center for Neurosciences Berlin, Berlin, Germany.
  • Hamel E; Faculty of Rehabilitation Medicine and Institute for Neuroscience and Mental Health, University of Alberta, Edmonton, AB, Canada.
  • Hanley DF; Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Härtig W; Department of Neurology, Center for Stroke Research Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Hummel FC; Berlin Institute of Health, Berlin, Germany.
  • Ikhsan M; Department of Neurosurgery, School of Medicine, University of Warmia and Mazury, Olsztyn, Poland.
  • Janowski M; Neurosurgical Trials Group, Institute of Neuroscience, The University of Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom.
  • Jolkkonen J; Laboratory of Cerebrovascular Research, Montreal Neurological Institute, McGill University, Montreal, QC, Canada.
  • Karuppagounder SS; Division of Brain Injury Outcomes, Johns Hopkins University, Baltimore, MD, United States.
  • Keep RF; Paul Flechsig Institute of Brain Research, University of Leipzig, Leipzig, Germany.
  • Koerte IK; Clinical Neuroengineering, Center for Neuroprosthetics and Brain Mind Institute, Swiss Federal Institute of Technology Valais, Clinique Romande de Réadaptation, Sion, Switzerland.
  • Kokaia Z; Clinical Neuroscience, University of Geneva Medical School, Geneva, Switzerland.
  • Li P; Institute for Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, Lübeck, Germany.
  • Liu F; Fraunhofer Research Institution for Marine Biotechnology and Cell Technology, Lübeck, Germany.
  • Lizasoain I; Institute for Medical and Marine Biotechnology, University of Lübeck, Lübeck, Germany.
  • Ludewig P; Department of Diagnostic Radiology and Nuclear Medicine, University of Maryland, Baltimore, MD, United States.
  • Metz GAS; Department of Neurology, A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
  • Montagne A; Burke Neurological Institute, White Plains, NY, United States.
  • Obenaus A; Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, United States.
  • Palumbo A; Department of Neurosurgery, University of Michigan, Ann Arbor, MI, United States.
  • Pearl M; Psychiatric Neuroimaging Laboratory, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.
  • Perez-Pinzon M; Department of Child and Adolescent Psychiatry, Psychosomatic, and Psychotherapy, Ludwig Maximilians University, Munich, Germany.
  • Planas AM; Lund Stem Cell Center, Lund University, Lund, Sweden.
  • Plesnila N; Department of Anesthesiology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
  • Raval AP; Department of Neurology, The University of Texas Health Science Center at Houston, McGovern Medical School, Houston, TX, United States.
  • Rueger MA; Unidad de Investigación Neurovascular, Departamento Farmacología y Toxicología, Facultad de Medicina, Instituto Universitario de Investigación en Neuroquímica, Universidad Complutense de Madrid, Madrid, Spain.
  • Sansing LH; Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Sohrabji F; Department of Neuroscience, Canadian Centre for Behavioural Neuroscience, University of Lethbridge, Lethbridge, AB, Canada.
  • Stagg CJ; Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.
  • Stetler RA; Department of Pediatrics, University of California, Irvine, Irvine, CA, United States.
  • Stowe AM; Institute for Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, Lübeck, Germany.
  • Sun D; Fraunhofer Research Institution for Marine Biotechnology and Cell Technology, Lübeck, Germany.
  • Taguchi A; Institute for Medical and Marine Biotechnology, University of Lübeck, Lübeck, Germany.
  • Tanter M; The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • Vay SU; Peritz Scheinberg Cerebral Vascular Disease Research Laboratory, Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, United States.
Front Aging Neurosci ; 13: 623751, 2021.
Article em En | MEDLINE | ID: mdl-33584250
ABSTRACT
The past decade has brought tremendous progress in diagnostic and therapeutic options for cerebrovascular diseases as exemplified by the advent of thrombectomy in ischemic stroke, benefitting a steeply increasing number of stroke patients and potentially paving the way for a renaissance of neuroprotectants. Progress in basic science has been equally impressive. Based on a deeper understanding of pathomechanisms underlying cerebrovascular diseases, new therapeutic targets have been identified and novel treatment strategies such as pre- and post-conditioning methods were developed. Moreover, translationally relevant aspects are increasingly recognized in basic science studies, which is believed to increase their predictive value and the relevance of obtained findings for clinical application.This review reports key results from some of the most remarkable and encouraging achievements in neurovascular research that have been reported at the 10th International Symposium on Neuroprotection and Neurorepair. Basic science topics discussed herein focus on aspects such as neuroinflammation, extracellular vesicles, and the role of sex and age on stroke recovery. Translational reports highlighted endovascular techniques and targeted delivery methods, neurorehabilitation, advanced functional testing approaches for experimental studies, pre-and post-conditioning approaches as well as novel imaging and treatment strategies. Beyond ischemic stroke, particular emphasis was given on activities in the fields of traumatic brain injury and cerebral hemorrhage in which promising preclinical and clinical results have been reported. Although the number of neutral outcomes in clinical trials is still remarkably high when targeting cerebrovascular diseases, we begin to evidence stepwise but continuous progress towards novel treatment options. Advances in preclinical and translational research as reported herein are believed to have formed a solid foundation for this progress.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Aging Neurosci Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Aging Neurosci Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido